Industry News
Synthetic biologists use bacterial superglue for faster vaccine development
1/20/2016
An interdisciplinary team of Oxford University researchers has devised a new technique to speed up the development of novel vaccines.Many vaccines are based around virus-like particles (VLPs).
Macmillan Cancer Support says 'don't tell cancer patients to take it easy'
1/20/2016
Charity says patients need support from friends and family in order to reap the many benefits of physical activity.
Liver Function: What Does The Liver Do?
1/20/2016
The liver is the largest solid organ in the body and carries out at least 500 roles. Here we will learn what happens when it goes wrong and how to keep it in top condition.
New target identified for reducing cancer metastasis
1/19/2016
A protein that is constantly expressed by cancer cells and quiescent in healthy ones appears to be a solid target for reducing cancer's ability to spread, scientists report.
Study compares health care usage, costs in developed countries for patients dying with cancer
1/19/2016
The first international comparative study of end-of-life care practices finds that the United States actually has the lowest proportion of deaths in the hospital and the lowest number of days in...
Among family members of older patients who died of advanced-stage cancer, earlier hospice enrollment, avoidance of intensive care unit (ICU) admissions within 30 days of death, and death occurring...
Laws of nature predict cancer evolution
1/19/2016
Cancers evolve over time in patterns governed by the same natural laws that drive physical and chemical processes as diverse as the flow of rivers or the brightness of stars, a new study reports.
Easier diagnosis for fungal infection of the lungs
1/19/2016
A new clinical imaging method developed in collaboration with a University of Exeter academic may enable doctors to tackle one of the main killers of patients with weakened immune systems sooner...
New findings may enhance PARP inhibitors therapy in breast cancer
1/19/2016
Findings from a new study reveal that PARP inhibitors, an emerging class of drugs being studied in cancer clinical trials, may be enhanced by combining them with inhibitors targeting an oncogene...